Kayla Tausche is an on-air correspondent based at CNBC's Washington, D.C. bureau and focuses on the intersection of government and business. Her reporting appears on television and CNBC's digital platforms. She also serves as a fill-in anchor for the network's Business Day programming.
Most recently, Tausche was co-anchor of CNBC's "Squawk Alley" (M-F, 11AM-12PM ET) and focused on the big money backing technology and innovation. She has also covered the banking industry, as well as corporate finance and deals— and frequently breaks news. Since joining CNBC in 2011, Tausche has reported on a wide variety of high-profile stories, including the historic Brexit vote, the Facebook, Twitter and Alibaba IPOs, the Occupy Wall Street movement, the MF Global bankruptcy and the News Corp. phone hacking scandal. Tausche began her journalism career with posts at the Associated Press in Brussels, Bloomberg News in New York, and DealReporter in New York and London.
An Atlanta native, Tausche graduated with honors in business journalism and international politics from University of North Carolina at Chapel Hill, where she was an Ameel J. Fisher scholar. She sits on the alumni board of the UNC journalism school.
Follow Kayla Tausche on Twitter @kaylatausche.
Intarcia Therapeutics Inc. said it raised $225 million in the latest in a series of financing to support the development of its implantable drug-delivery pump for patients with diabetes.Kurt Graves, Intarcia Therapeutics chairman and CEO, discusses.